This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sanofi-Aventis. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Bernard Pirard: Innovator in Pharmaceutical Chemistry
Introduction
Bernard Pirard is a notable inventor based in Hegenheim, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical health issues.
Latest Patents
One of his key inventions is a patent for pyrazolopyridine derivatives as inhibitors of β-adrenergic receptor kinase 1. This invention relates to 6-amido substituted pyrazolopyridine derivatives, which are useful in treating and preventing chronic heart failure, hypertension, myocardial ischemia, and hepatitis C virus infections. Additionally, these compounds may help in the prevention of opiate addiction. Bernard holds 1 patent for this innovative work.
Career Highlights
Bernard Pirard is associated with Sanofi-Aventis, a leading global pharmaceutical company. His work there has focused on developing new therapeutic strategies to address various health challenges.
Collaborations
He has collaborated with notable colleagues such as Henning Steinhagen and Jochen Huber, contributing to advancements in their shared field of expertise.
Conclusion
Bernard Pirard's innovative work in pharmaceutical chemistry exemplifies the impact of targeted research on public health. His contributions continue to pave the way for new treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile